Diaceutics believe that every patient should get the treatment they deserve. We have worked on every Precision Medicine brought to market and we are trusted by the world's leading pharmaceutical companies. Find out about DXRX - the Diagnostic Network for Precision Medicine.
Employees: 51-200
Total raised: $5.27M
Founded date: 2005
Investors 2
| Date | Name | Website |
| - | Co-FundNI | cofundni.c... |
| - | Clarendon ... | clarendon-... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.04.2018 | - | $5.27M | - |
Mentions in press and media 17
| Date | Title | Description |
| 28.10.2024 | Cutting Through the Noise: Data-Driven Physician Engagement in Precision Medicine, Upcoming Webinar Hosted by Xtalks | www.diaceutics.com In this free webinar, learn why precision medicine commercial success requires a different approach to clinical education. Attendees will learn how prospective diagnostics data can be used to reach physicians at the right... |
| 24.09.2024 | Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine, Upcoming Webinar Hosted by Xtalks | www.diaceutics.com In this free webinar, learn how precision medicines require a shift from a traditional launch strategy and how leveraging real-world data can enhance the commercialization strategy, increase therapy adoption and help iden... |
| 21.08.2024 | Driving Commercial Success for Precision Medicine: Understand the Market to Maximize Patient Identification and Therapy Adoption, Upcoming Webinar Hosted by Xtalks | www.diaceutics.com In this free webinar, learn about evaluating the market landscape for commercialization opportunities and optimizing therapy adoptions. Attendees will understand how real-world data (RWD) can provide insights on market te... |
| 10.06.2024 | Diaceutics announces "Precision Medicine in Oncology " Virtual Event: A Cutting-Edge Exploration of Cancer Diagnostics & Treatment | Diaceutics PLC (AIM: DXRX), a leading technology & solutions provider to the pharma & biotech industry, is pleased to announce its upcoming virtual event. "Precision medicine in oncology," on 19 June, 2024. BELFAST, Northe... |
| 14.07.2023 | Don’t miss Diaceutics virtual event: Unlocking the Future of Solid Tumor Treatment | Precision Medicine in Solid Tumors BELFAST, Northern Ireland (PRWEB) July 14, 2023 Diaceutics, the leading data analytics and implementation services provider powering diagnostic commercialization for precision medicine, is excited to annou... |
| 26.08.2020 | Belfast-based Diaceutics raises £4 million to speed up diagnostic testing for new drugs | Diaceutics, a Belfast-based data analytics company working in precision medicine diagnostics, has raised £4 million from Silicon Valley Bank’s UK Branch (SVB). Following a three year plan, the working capital will fuel global expansion and ... |
| 19.03.2019 | Diaceutics IPO Set To Raise £17m | Diaceutics plc is set to list on the London Stock Exchange this week in a flotation that values the company at c. £53m. Diaceutics is involved in diagnostics data analytics and implementation services for the global pharmaceutical industry.... |
| 18.03.2019 | Diaceutics to List on London Stock Exchange | Diaceutics plc, a revenue-generating and profitable diagnostics data analytics and implementation services company which services the global pharmaceutical industry, is seeking a listing on the AIM Market of the London Stock Exchange. The c... |
| 05.04.2018 | Diaceutics Raises $5M in Mezzanine Financing | Diaceutics, a Parsippany, N.J.-based diagnostic commercialization company, raised $5m in new mezzanine financing. Backers included WhiteRock Capital Partners and Silicon Valley Bank. The company will use the funds to invest in the data anal... |
| 05.04.2018 | Irish medtech startup Diaceutics raises €4.3 million in mezzanine funding | Diaceutics, an Irish medtech startup, has raised €4.3 million in mezzanine financing from WhiteRock Capital Partners and Capital Partners. Through this mezzanine funding round the investors have provided capital in the form of debt with the... |
Show more